US 11,672,969 B2
Minimally invasive implantable neurostimulation system
Anthony M. Chasensky, St. Paul, MN (US); Bernard Q. Li, Plymouth, MN (US); Brad C. Tischendorf, Minneapolis, MN (US); Chris J. Paidosh, Minneapolis, MN (US); Christian S. Nielsen, River Falls, WI (US); Craig L. Schmidt, Eagan, MN (US); David A. Dinsmoor, St. Paul, MN (US); Duane L. Bourget, Minneapolis, MN (US); Eric H. Bonde, Minnetonka, MN (US); Erik R. Scott, Maple Grove, MN (US); Forrest C M Pape, New Brighton, MN (US); Gabriela C. Molnar, Blaine, MN (US); Gordon O. Munns, Stacy, MN (US); Joel A. Anderson, Brooklyn Park, MN (US); John E. Kast, Hugo, MN (US); Joseph J. Viavattine, Vadnais Heights, MN (US); Markus W. Reiterer, Plymouth, MN (US); Michael J. Ebert, Fridley, MN (US); Phillip C. Falkner, Minneapolis, MN (US); Prabhakar A. Tamirisa, Brooklyn Park, MN (US); Randy S. Roles, Elk River, MN (US); Reginald D. Robinson, Plymouth, MN (US); Richard T. Stone, Minneapolis, MN (US); Shawn C. Kelley, Shoreview, MN (US); Stephen J. Roddy, Minneapolis, MN (US); Thomas P. Miltich, Otsego, MN (US); Timothy J. Denison, Minneapolis, MN (US); Todd V. Smith, Shoreview, MN (US); and Xuan K. Wei, Minnetonka, MN (US)
Assigned to Medtronic, Inc., Minneapolis, MN (US)
Filed by Medtronic, Inc., Minneapolis, MN (US)
Filed on Aug. 25, 2020, as Appl. No. 16/947,954.
Application 16/281,573 is a division of application No. 14/098,608, filed on Dec. 6, 2013, granted, now 10,258,789, issued on Apr. 16, 2019.
Application 16/947,954 is a continuation of application No. 16/281,573, filed on Feb. 21, 2019, abandoned.
Claims priority of provisional application 61/777,824, filed on Mar. 12, 2013.
Claims priority of provisional application 61/777,787, filed on Mar. 12, 2013.
Claims priority of provisional application 61/777,949, filed on Mar. 12, 2013.
Claims priority of provisional application 61/777,838, filed on Mar. 12, 2013.
Claims priority of provisional application 61/777,804, filed on Mar. 12, 2013.
Claims priority of provisional application 61/734,446, filed on Dec. 7, 2012.
Claims priority of provisional application 61/734,436, filed on Dec. 7, 2012.
Claims priority of provisional application 61/734,425, filed on Dec. 7, 2012.
Claims priority of provisional application 61/734,429, filed on Dec. 7, 2012.
Prior Publication US 2020/0384261 A1, Dec. 10, 2020
Int. Cl. A61N 1/02 (2006.01); A61B 17/00 (2006.01); A61N 1/05 (2006.01); A61N 1/372 (2006.01); A61N 1/375 (2006.01); A61N 1/36 (2006.01); A61N 1/378 (2006.01)
CPC A61N 1/02 (2013.01) [A61B 17/00234 (2013.01); A61N 1/05 (2013.01); A61N 1/0551 (2013.01); A61N 1/3605 (2013.01); A61N 1/36007 (2013.01); A61N 1/36057 (2013.01); A61N 1/36067 (2013.01); A61N 1/36071 (2013.01); A61N 1/36139 (2013.01); A61N 1/3727 (2013.01); A61N 1/3754 (2013.01); A61N 1/3756 (2013.01); A61N 1/3787 (2013.01); A61N 1/37205 (2013.01); A61N 1/37223 (2013.01); A61N 1/37235 (2013.01); A61N 1/37247 (2013.01); A61N 1/36021 (2013.01); A61N 1/36053 (2013.01); A61N 1/37211 (2013.01); A61N 1/37518 (2017.08); F04C 2270/0421 (2013.01)] 22 Claims
OG exemplary drawing
 
1. A system for providing a tibial nerve stimulation therapy to a patient, the system comprising:
an implantable tibial nerve stimulation device for treatment of one or more symptoms associated with an overactive bladder, the implantable tibial nerve stimulation device comprising:
a first end;
a second end;
electronic circuitry for controlling operation of the implantable tibial nerve stimulation device, the electronic circuitry including:
a control unit;
circuitry for creating an electrical pulse suitable for stimulating a nerve as part of the tibial nerve stimulation therapy;
a power receiving element;
a power regulator coupled to the power receiving element; and
a plurality of electrodes coupled to the circuitry for creating an electrical pulse, and configured for delivering the tibial nerve stimulation therapy to the patient,
wherein the implantable tibial nerve stimulation device is configured to be implanted in a region of a medial malleolus of the patient, and
wherein the implantable tibial nerve stimulation device is further configured to deliver the tibial nerve stimulation therapy to a tibial nerve of the patient; and
an external device selectively coupleable with the implantable tibial nerve stimulation device when the external device is positioned in proximity to the implantable tibial nerve stimulation device, the external device including:
a power supply;
a controller;
a power transfer control module;
a power transfer element; and
a user interface configured to allow a user to adjust one or more aspects of the tibial nerve stimulation therapy,
the external device being operable to transmit power to the implantable tibial nerve stimulation device from the power transfer element of the external device to the power receiving element of the implantable tibial nerve stimulation device,
the external device configured to receive a feedback signal from the implantable tibial nerve stimulation device to control power transfer between the external device and the implantable tibial nerve stimulation device,
wherein the user interface of the external device includes a button that allows a patient to start the tibial nerve stimulation therapy or stop the tibial nerve stimulation therapy, and
wherein the power regulator of the implantable tibial nerve stimulation device is configured to receive power from the external device via the power receiving element, and is further configured to provide a rectified voltage signal to the circuitry for creating an electrical pulse to deliver the tibial nerve stimulation therapy via one or more of the plurality of electrodes.